Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 10.38
0.00 (0.00%)
Aug 21, 2026, 5:35 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €142.53 million as of August 21, 2026. Its market cap has decreased by -0.55% in one year.
Market Cap
142.53M
Enterprise Value
391.83M
Revenue
649.17M
Ranking
n/a
PE Ratio
15.19
Stock Price
€10.38
ChartMarket Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 142.53M, an increase of 25.19%. That is a compound annual growth rate of 0.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 142.53M | -23.60% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 93.20B |
| EssilorLuxottica Société anonyme | 74.09B |
| Sartorius Stedim Biotech | 18.97B |
| Ipsen | 13.40B |
| Cellectis | 215.19M |
| Eurobio Scientific Société anonyme | 205.39M |
| Median Technologies | 171.74M |
| Bastide Le Confort Médical | 168.26M |